Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sjaak Burgers

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|May 1, 2014
[Is one single exposure to asbestos life-threatening?]Paul Baas, J A Sjaak Burgers
ERJ Open Research|March 9, 2023
Broadening the scope for three-dimensional printed airway stentsSophia van Beelen, Illaa Smesseim, Nicolas Guibert, et al.
Chest|March 16, 2006
Fluorescence detection of pleural malignancies using 5-aminolaevulinic acidPaul Baas, Martijn Triesscheijn, Sjaak Burgers, et al.
Thoracic Surgery Clinics|November 24, 2004
Malignant pleural mesothelioma: overview of the North American and European experienceJasleen Kukreja, Michael T Jaklitsch, Daniel C Wiener, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancerMarina Kartachova, Nico van Zandwijk, Sjaak Burgers, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastasesMargriet Kwint, Iris Walraven, Sjaak Burgers, et al.
Molecular Imaging and Biology|September 17, 2009
Predicting early chemotherapy response with technetium-99m methoxyisobutylisonitrile SPECT/CT in advanced non-small cell lung cancerTzu-I J Yang, Tjeerd S Aukema, Harm van Tinteren, et al.
European Journal of Cancer Care|August 2, 2021
The psychosocial impact of living with mesothelioma: Experiences and needs of patients and their carers regarding supportive careAgata Prusak, Jan Maarten van der Zwan, Mieke J Aarts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesotheliomaAndrew Bottomley, Corneel Coens, Fabio Efficace, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup StudyAndrew Bottomley, Rabab Gaafar, Rabab Gaafa, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Nederlands Tijdschrift Voor Geneeskunde|May 1, 2014
[Is one single exposure to asbestos life-threatening?]Paul Baas, J A Sjaak Burgers
ERJ Open Research|March 9, 2023
Broadening the scope for three-dimensional printed airway stentsSophia van Beelen, Illaa Smesseim, Nicolas Guibert, et al.
Chest|March 16, 2006
Fluorescence detection of pleural malignancies using 5-aminolaevulinic acidPaul Baas, Martijn Triesscheijn, Sjaak Burgers, et al.
Thoracic Surgery Clinics|November 24, 2004
Malignant pleural mesothelioma: overview of the North American and European experienceJasleen Kukreja, Michael T Jaklitsch, Daniel C Wiener, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancerMarina Kartachova, Nico van Zandwijk, Sjaak Burgers, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastasesMargriet Kwint, Iris Walraven, Sjaak Burgers, et al.
Molecular Imaging and Biology|September 17, 2009
Predicting early chemotherapy response with technetium-99m methoxyisobutylisonitrile SPECT/CT in advanced non-small cell lung cancerTzu-I J Yang, Tjeerd S Aukema, Harm van Tinteren, et al.
European Journal of Cancer Care|August 2, 2021
The psychosocial impact of living with mesothelioma: Experiences and needs of patients and their carers regarding supportive careAgata Prusak, Jan Maarten van der Zwan, Mieke J Aarts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesotheliomaAndrew Bottomley, Corneel Coens, Fabio Efficace, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup StudyAndrew Bottomley, Rabab Gaafar, Rabab Gaafa, et al.
Pageof 3